SEC Form D · filed March 11, 2020
Akari Therapeutics Plc
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Michael Grissinger · London, United KingdomDirectorDonald Williams · London, United KingdomDirectorPeter Feldschreiber · London, United KingdomDirectorClive Richardson · London, United KingdomExec · DirectorDavid Byrne · London, United KingdomDirectorStuart Ungar · London, United KingdomDirectorRay Prudo · London, United KingdomDirectorJames Hill · London, United KingdomDirectorJeffrey O'Donohue · TOLUCA LAKE, CADirectorPeter Feldschreiber · London, United KingdomDirectorAike Ho · Oakland, CADirectorGerard Cuddy · Irvine, CADirectorEslie C. Sykes · Raleigh, NCExec · DirectorJeffrey Zhao · West Hollywood, CADirectorEric Wiesen · Oakland, CADirectorSara Y. Huda · Grand Duchy of Luxembourg, LuxembourgDirectorMariel A. Joliet · HOUSTON, TXDirectorGeorge E. Marucci, Jr · HOUSTON, TXDirectorSusan C. Schnabel · HOUSTON, TXDirectorDouglas L. Goodwillie · HOUSTON, TXDirectorKenneth B. Leonard · HOUSTON, TXExec · DirectorTerry A. Hart · HOUSTON, TXDirectorMichael J. O'Neil · HOUSTON, TXDirectorJohn B. Riley · HOUSTON, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗